Torrent has been predominantly a chronic therapies-focused company, and as a result, our R&D and manufacturing, among others, is geared up towards developing this segment. Edited excerpts: Torrent has limited presence in Covid therapies. He tells Sohini Das, in an interview, that the group’s succession planning among the cousins is being worked out. Aman Mehta, chief marketing officer, India business, Torrent Pharmaceuticals, says the company is evaluating potential acquisition targets over the last few quarters. A novel chemical entity (NCE), which was under development for 10 years, is now in Phase-3 clinical trials. Ahmedabad-based Torrent Pharmaceuticals is gearing up to launch its first novel drug in diabetes in the second half of the next financial year.
0 Comments
Leave a Reply. |